This is how Australia plans to keep the new Pfizer vaccine at -70℃

Australia's first shipment of the Pfizer vaccine is curently being stored and will be distributed in top secret by global logistics firm DHL since it touched down from Belgium last week. This batch of Covid-19 vaccine must be stored below -70℃ before being distributed to 200 cold storage facilities around the country, DHL has revealed.

It has been described as the 'largest logistic program' for DHL in Australia's history, the logistics giant will store hundreds of thousands of doses of the vaccine in specialised freezers in a secret location at a covert warehouse to make sure they stay safe and secure at the right temperature to ensure the stability of the vaccines.

Pfizer says after storage for up to 30 days in their thermal shipper, their vaccine can be stored for an additional five days at 2-8℃. Once thawed or used, it cannot be re-frozen and stored. The ultra-cold temperature requirement makes transporting and storing problematic and difficult. 

Ultra-Low Temperature refrigerators and transport coolers are the key to solving the nightmare of storage and logistics for these vaccines. Within this strategy in Australia, Haier Biomedical's Ultra-Low Temperature Freezers are being used and will play a vital role in the complete process for the vaccination program.

The choice of Haier Biomedical solutions is due to its superior product performance: guaranteed temperature uniformity, the TwinCool refrigeration system, and through the Internet of Things, it achieves full monitoring and alarms to maximize vaccine safety"

In addition to the strict requirements for -70°C in the storage and transportation of the mRNA Covid-19 vaccine, Haier Biomedical has formulated solutions to overcome any possible problems encountered by vaccines in different temperature ranges of -70℃, -20℃ and 2-8℃ respectively, providing security and guarantee for stable vaccine transportation, preservation, management and monitoring to inoculation. At the same time, considering different region’s needs, Haier Biomedical provides multiple solutions for different countries to meet their vaccine safety requirements. To date, Haier Biomedical has successively provided Covid-19 vaccine product solutions for the United States, the Czech Republic, Yemen, Vietnam, Singapore, the Philippines, Costa Rica and many other countries, and has been greatly recognized as the right choice for the storage and distribution of COVID-19 vaccines.

Haier Biomedical insists on the intelligent protection of life, by empowering science and technology, and is committed to providing the best biological cold chain products and solutions to the world, enhancing the safety and protection of all vaccines!